Missouri's inaugural month of legal sports betting attracted over $540 million in wagers, but aggressive promotions led to a net revenue loss for operators, even as the state collected millions in fees and taxes.
President Donald Trump has announced his intention to nominate Kevin Warsh, a former Federal Reserve governor and seasoned financial crisis veteran, to chair the central bank. The move signals a potential shift in monetary policy direction and reignites debates over Fed independence.
Axon Enterprise stock fell sharply this week, caught in a sector-wide downturn for software stocks driven by AI disruption fears and valuation concerns, despite a lack of company-specific negative news.
ExxonMobil and Chevron signal that significant investment in Venezuela's vast oil reserves hinges on clearer legal and fiscal stability, despite recent political changes and White House pressure.
American Express reported fourth-quarter earnings that slightly trailed analyst forecasts, prompting a share price decline. Despite the near-term miss, the company issued strong forward guidance for 2026 and announced a significant dividend hike, underscoring confidence in its long-term growth trajectory driven by card member spending and fee growth.
Ahead of its Q4 2025 results, Citigroup has revised its price target for PDD Holdings downward, maintaining a Neutral stance. The adjustment reflects concerns over slowing Chinese consumer spending and rising operational costs for its international platform, Temu.
Shares of Chinese data center operator VNET Group have skyrocketed over the past year, with the majority of Wall Street analysts maintaining Buy ratings and projecting significant further upside, fueled by strong demand for digital infrastructure.
HSBC has raised its rating on New Oriental Education & Technology Group (NYSE: EDU) from 'Hold' to 'Buy', following the company's better-than-expected Q2 FY2026 results. The upgrade highlights a robust recovery in core businesses and strategic expansion into new educational initiatives.
A stunning reversal wiped out months of gains for precious metals on Friday, with gold futures tumbling to $4,800 and silver recording a historic single-day drop, sparking fears of a volatile new phase for commodity markets.
The launch of ChatGPT in late 2022 didn't just spark an AI revolution—it ignited a historic run for Nvidia stock. We examine how a modest, timely investment transformed into a five-figure sum, and what it reveals about investing in paradigm shifts.
A couple earning $380,000 annually faces a classic high-cost dilemma: Should they stretch for a $1.8 million dream home now or wait? With a hefty down payment saved but significant student debt, their debate highlights the tension between future earnings potential and present financial anxiety in today's premium housing markets.
A sharp, unexpected jump in wholesale prices complicates the White House's economic narrative and its pressure campaign on the Federal Reserve for rate cuts.
Damascus has declared its intention to permanently close the sprawling al-Hol and Roj displacement camps in northeast Syria, which house over 28,000 people connected to the Islamic State. The move, confirmed by officials and aid groups, sparks urgent debate about the future of detainees, including foreign nationals.
The leading U.S. liquefied natural gas exporter, Cheniere Energy, has declared a quarterly cash dividend of $0.555 per share, reinforcing its commitment to shareholder returns even as analysts adjust near-term price targets.
A former investment advisor with ties to major Wall Street firms has been sentenced to six years behind bars for orchestrating a million-dollar fraud scheme, using client funds to finance a luxury lifestyle that included high-end cars and country club memberships.
President Trump's nomination of former Fed Governor Kevin Warsh to lead the central bank has ignited market speculation over the future path of interest rates, with analysts divided on whether his leadership would mean more cuts or a return to hawkish restraint.
Regeneron Pharmaceuticals is positioning its experimental obesity drug, olatorepatide, as a potential game-changer by combining significant weight loss with a dramatic reduction in 'bad' cholesterol. The company believes this dual benefit could carve out a unique niche in the competitive $150 billion market, currently led by Novo Nordisk and Eli Lilly.
President Trump's nomination of former Fed governor Kevin Warsh to lead the central bank has sparked immediate concerns on Wall Street about political influence over monetary policy, setting the stage for a contentious Senate confirmation battle.
Chevron capped off a year of strategic execution with record global production and industry-leading free cash flow growth, while outlining ambitious expansion plans from the Caspian to the Caribbean.
Amidst a choppy market, value investors are hunting for bargains. We spotlight three companies—Dingdong, Origin Bancorp, and ATRenew—whose current share prices appear significantly disconnected from their estimated intrinsic value, presenting potential opportunities for the discerning investor.
